ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)

CUSIP: 682310875

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock, no par value
Shares outstanding
109,272,143
Total 13F shares
590,438
Share change
+174,555
Total reported value
$816,220
Price per share
$1.39
Number of holders
28
Value change
+$77,206
Number of buys
10
Number of sells
11

Security key

682310875

Report period

Q1 2020

Institutions

28

Top holders

10

Top shareholders of ONCY - ONCOLYTICS BIOTECH INC - Common Stock, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
MORGAN STANLEY
13F
Company
0.13%
140,278
$668,000 31 Dec 2019
13F
ROYAL BANK OF CANADA
13F
Company
0.06%
60,165
$286,000 31 Dec 2019
13F
SCOTIA CAPITAL INC.
13F
Company
0.04%
47,227
$223,000 31 Dec 2019
13F
CITADEL ADVISORS LLC
13F
Company
0.03%
32,465
$154,000 31 Dec 2019
13F
CIBC WORLD MARKET INC.
13F
Company
0.02%
17,193
$82,000 31 Dec 2019
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0.01%
15,685
$74,270 31 Dec 2019
13F
COMERICA BANK
13F
Company
0.01%
15,526
$41,000 31 Dec 2019
13F
JANE STREET GROUP, LLC
13F
Company
0.01%
14,519
$69,000 31 Dec 2019
13F
Crescent Grove Advisors, LLC
13F
Company
0.01%
10,790
$51,000 31 Dec 2019
13F
LADENBURG THALMANN FINANCIAL SERVICES INC.
13F
Company
0.01%
8,390
$39,000 31 Dec 2019
13F
BANK OF MONTREAL /CAN/
13F
Company
0.01%
6,488
$31,000 31 Dec 2019
13F
Cedar Mountain Advisors, LLC
13F
Company
0.01%
5,651
$27,000 31 Dec 2019
13F
Patriot Financial Group Insurance Agency, LLC
13F
Company
0%
5,000
$24,000 31 Dec 2019
13F
TRUST CO OF VERMONT
13F
Company
0%
5,000
$24,000 31 Dec 2019
13F
IFP Advisors, Inc
13F
Company
0%
5,000
$14,000 31 Dec 2019
13F
tru Independence LLC
13F
Company
0%
3,500
$5,000 31 Dec 2019
13F
UBS Group AG
13F
Company
0%
3,000
$14,000 31 Dec 2019
13F
TORONTO DOMINION BANK
13F
Company
0%
1,800
$9,000 31 Dec 2019
13F
NEXT Financial Group, Inc
13F
Company
0%
1,472
$7,000 31 Dec 2019
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
1,261
$6,000 31 Dec 2019
13F
Retirement Group, LLC
13F
Company
0%
1,000
$5,000 31 Dec 2019
13F
Rockefeller Capital Management L.P.
13F
Company
0%
651
$3,000 31 Dec 2019
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
642
$3,000 31 Dec 2019
13F
DEUTSCHE BANK AG\
13F
Company
0%
503
$2,000 31 Dec 2019
13F
JNBA Financial Advisors
13F
Company
0%
210
$1,000 31 Dec 2019
13F

Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q1 2020

As of 31 Mar 2020, ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 590,438 shares. The largest 10 holders included TWO SIGMA ADVISERS, LP, Creative Planning, ROYAL BANK OF CANADA, SCOTIA CAPITAL INC., WEDBUSH SECURITIES INC, RENAISSANCE TECHNOLOGIES LLC, BANCO BILBAO VIZCAYA ARGENTARIA, S.A., CIBC World Markets Inc., COMERICA BANK, and INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC. This page lists 28 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders
23
Q1 2020 holders
28
Holder diff
5
Investor Q4 2019 Shares Q1 2020 Shares Share Diff Share Chg % Q4 2019 Value $ Q1 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .